Latest News about LGVN
Recent news which mentions LGVN
Why Is U Power (UCAR) Stock Up 69% Today?
April 08, 2024
From InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
April 08, 2024
From Benzinga
From InvestorPlace
Why Esperion Therapeutics Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
April 08, 2024
From Benzinga
From Benzinga
From Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
March 20, 2024
From Benzinga
From Benzinga
Earnings Scheduled For February 27, 2024
February 27, 2024
From Benzinga
BioRestorative Therapies Presents Promising Data At Orthopaedic Research Society (ORS) 2024 Annual Meeting
February 13, 2024
From Benzinga
Longeveron (NASDAQ: LGVN) Making Inroads With Lomecel-B™ – Biotech's Investigational Alzheimer's Treatment Shows Positive Trial Results
February 07, 2024
Tickers
LGVN
From Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
January 31, 2024
From Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
January 30, 2024
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
January 29, 2024
From Benzinga
Lineage Cell Therapeutics, Longeveron And 2 Other Stocks Under $2 Insiders Are Buying
January 03, 2024
From Benzinga
Nasdaq Gains 100 Points; CarMax Earnings Top Views
December 21, 2023
From Benzinga
Why CarMax Shares Are Trading Higher By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
December 21, 2023
From Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
December 21, 2023
From Benzinga
Crude Oil Moves Lower; Micron Issues Strong Forecast
December 21, 2023
From Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
December 20, 2023
From Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
December 05, 2023
From Benzinga
Longeveron (NASDAQ: LGVN) Announces Positive Top-Line Results For Its Phase 2a Clinical Trial For The Treatment Of Mild Alzheimer's Disease with Lomecel-B™
December 05, 2023
Tickers
LGVN
From Benzinga
Longeveron (NASDAQ: LGVN) Announces Positive Top-Line Results For Its Phase 2a Clinical Trial For The Treatment Of Mild Alzheimer's Disease with Lomecel-B™
December 05, 2023
Tickers
LGVN
From Benzinga
Earnings Scheduled For November 10, 2023
November 10, 2023
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.